Patient Care

Ignite Biomedical Achieves Key Milestone in Precision Medicine with Successful Analytical Validation of TNF-alpha Inhibitor Treatment Response Predictor

Validation Results Pave the Way for Clinical Studies Focused on Transforming Patient Outcomes inInflammatory BowelDisease FRAMINGHAM, MA / ACCESSWIRE /...

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of...

Black Book Highlights Global Surge in Cybersecurity Attacks Threatening Healthcare Systems Worldwide: UK, Australia, India, and Brazil Among Top Targets

Ransomware Threats Expose Critical Infrastructure Gaps, Endangering Patient Safety in Key Nations MELBOURNE, AUSTRALIA / ACCESSWIRE / December 9, 2024...

Artificial Intelligence in Medical Diagnostics Market to Hit USD 4.72 Billion by 2029 with 22.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla. , Dec. 9, 2024 /PRNewswire/ -- The global AI in medical diagnostics market is likely to grow from...

Hot Topics in Neonatology® 2024 Conference to Feature Symposium on Clinical Impact & Cost Savings of an Exclusive Human Milk Diet

Dr. Jenny Fox From Children's Hospital of Richmond at Virginia Commonwealth University to Present Published Data and Firsthand Insights on...

Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence

error: Content is protected !!